Yaws is a disfiguring, infectious skin disease.
It mainly affects children who live in poor, remote communities with limited access to health care.
It is said that “where the road ends, yaws begins”.
Yaws is curable with a single dose of oral antibiotic.
June 2015 | Geneva -- Some 13 countries in Africa, Asia and the Pacific are known to be endemic for yaws, with an estimated 89 million people living affected areas.
In almost 73 countries where the disease was endemic in the 1950s, the current status remains unknown.
May 2014| Geneva -- A new rapid diagnostic test to distinguish present and past infections is available.
The test is being deployed to support yaws eradication and monitor interruption of transmission.
This test will enhance eradication efforts.
February 2015 | Geneva -- In 2012 researchers in Papua New Guinea discovered that a single dose of azithromycin (an oral antibiotic) cured yaws.
This simple, inexpensive treatment has now nhanced the prospects of eradication.
Challenges and key research questions for yaws eradication
Global epidemiology of yaws: a systematic review
Yaws strategy development
WHO to investigate yaws in the Philippines decades after last recorded cases
Yaws eradication will need millions of donated antibiotics, says WHO
New trial confirms effectiveness of single-dose oral antibiotic, boosting prospects for yaws eradication
Consultation on eradication of yaws, 20–22 March 2013, CICG, Geneva, Switzerland